QuantumScape director sells 27,106 shares in plan

QuantumScape Corp director Jeffrey B. Straubel sold 27,106 shares of Class A Common Stock on January 5, 2026 at a weighted average price of $11.2776 per share under a Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

QuantumScape Corp director Jeffrey B. Straubel sold 27,106 shares of Class A Common Stock on January 5, 2026 at a weighted average price of $11.2776 per share under a Rule 10b5-1 trading plan.

The transactions were executed pursuant to a pre-arranged Rule 10b5-1 plan adopted on June 13, 2025 and involved multiple trades at prices between $11.055 and $11.545.

After these sales, Straubel beneficially owned 239,722 shares of QuantumScape Class A Common Stock, including 48,192 shares represented by restricted stock units that deliver one share each if vesting and service conditions are met.

Insider Trade Summary

Net Seller: 27,106 shares

Net Sell 1 txn

Insider Straubel Jeffrey B

Role Director

Sold 27,106 shs ($306K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	27,106	$11.2776	$306K

Holdings After Transaction: Class A Common Stock — 239,722 shares (Direct)

Footnotes (3)

1. F1. The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.
2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.055 to $11.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
3. F3. Includes 48,192 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Class A Common Stock of the Issuer per the applicable vesting schedule, subject to the Reporting Person's continued service as of each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did QuantumScape (QS) report in this Form 4?

The Form 4 reports that director Jeffrey B. Straubel sold 27,106 shares of QuantumScape Class A Common Stock on January 5, 2026.

At what price did Jeffrey Straubel sell QuantumScape (QS) shares?

The shares were sold at a weighted average price of $11.2776 per share, with individual trades occurring between $11.055 and $11.545.

Was the QuantumScape (QS) insider sale made under a Rule 10b5-1 plan?

Yes. The sale was carried out under a Rule 10b5-1 trading plan that Jeffrey Straubel adopted on June 13, 2025.

How many QuantumScape (QS) shares does Jeffrey Straubel own after this transaction?

Following the sale, Jeffrey Straubel beneficially owned 239,722 shares of QuantumScape Class A Common Stock.

How many QuantumScape (QS) RSUs are included in Straubel’s holdings?

His beneficial ownership includes 48,192 shares represented by restricted stock units (RSUs), each RSU delivering one share if vesting and service conditions are satisfied.

What does it mean that the QuantumScape (QS) insider sale used a weighted average price?

It means the $11.2776 figure is an average across multiple trades, with actual sale prices ranging from $11.055 to $11.545 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/07/2026 - 06:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Straubel Jeffrey B

(Last) (First) (Middle)

C/O QUANTUMSCAPE CORPORATION

1730 TECHNOLOGY DRIVE

(Street)

SAN JOSE CA 95110

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QuantumScape Corp [ QS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/05/2026		S(1)		27,106	D	$11.2776(2)	239,722(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.055 to $11.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

3. Includes 48,192 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Class A Common Stock of the Issuer per the applicable vesting schedule, subject to the Reporting Person's continued service as of each vesting date.

Remarks:

	/s /Michael O McCarthy III, attorney-in-fact	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.